Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11148524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With the use of the PFA-100 platelet function analyzer to evaluate primary hemostasis in whole blood, measured as closure time (CT), neonates had shorter CTs than members of an adult control group. Multivariate analysis of measures that contribute to primary hemostasis showed that higher hematocrits and increased ristocetin cofactor activity were the best correlates for CTs of cord blood. These 2 factors may also enhance primary hemostasis in vivo and compensate for the impaired platelet function of the newborn.
Medical subject headings
- Fetal Blood
- Hemostasis
- Infant, Newborn
- Platelet Function Tests